C19-9 (1477482-47-5) is a novel non-RGD inhibitor of the integrin alphavß3 receptor (KD = 102 nM). It was active against the human prostate carcinoma epithelial cell line 22RV1 (IC50 = 467 nM) and human prostate cancer organoids (IC50 = 652 nM). C19-9 was ac
* VAT and and shipping costs not included. Errors and price changes excepted